ChatDiagram
genetics · healthcare

Lynch syndrome hereditary cancer pedigree

A Lynch syndrome pedigree records the family relationships and health-status pattern that can inform hereditary cancer assessment. It should distinguish affected relatives, known carriers, unaffected relatives, and the proband whose history prompted the chart. Arrange the family by generation and keep each child below the relevant parent pair. This drawing is useful for teaching genetics or preparing a concise family-history summary. It is not a diagnosis: cancer history, ages at diagnosis, pathology, and genetic test results need review by an appropriate clinician or genetic counselor. Keep sensitive details limited to the people who need to see them. Store and share it using appropriate privacy safeguards.

類型 系譜圖標準 NSGC Pedigree Standardization (Bennett 2008)引擎 schematex-pedigree更新時間 2026/9/24
Lynch Syndrome Family Pedigree
Drawing preview
需求

“Draw a three-generation Lynch syndrome pedigree with an affected deceased grandfather, an affected daughter, a carrier son, an unaffected daughter, and an affected female proband with one unaffected sibling.”

接著試試Add an age-at-diagnosis note for the proband.Add a genetic testing result for the carrier son.
這張圖裡有什麼

看懂背後的決策。

01Choose inheritance mode

Use an autosomal-dominant pedigree header.

02Mark affected relatives

Distinguish the cancer pattern across generations.

03Record carrier status

Keep known genetic results visible.

04Identify the proband

Mark the person whose family history prompted assessment.

Use this as a teaching or planning diagram for a hereditary-cancer family history; clinical decisions require qualified review.

瀏覽所有 系譜圖 範本 →

常見問題

常見問題

What is a hereditary cancer pedigree?

It is a family diagram that records relationships and cancer-related status across generations.

What does a proband mean?

The proband is the person whose history led to the family assessment or chart.

Can a pedigree diagnose Lynch syndrome?

No. It organizes family history; diagnosis and testing decisions require qualified clinical review.